Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dinan

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Trauma and Acute Care Surgery|July 25, 2014
An acute care surgery fellowship benefits a general surgical residencyKelly A Dinan, James W Davis, Mary M Wolfe, et al.
BMC Bioinformatics|February 27, 2010
SplicerAV: a tool for mining microarray expression data for changes in RNA processingTimothy J Robinson, Michaela A Dinan, Mark Dewhirst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid CancerTimothy J Robinson, Samantha Thomas, Michaela A Dinan, et al.
Endocrine|December 29, 2015
Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancerEwa Ruel, Samantha Thomas, Michaela A Dinan, et al.
Journal of General Internal Medicine|August 22, 2006
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosureKevin P Weinfurt, Joëlle Y Friedman, Jennifer S Allsbrook, et al.
JAMA Network Open|June 10, 2025
Biomarker-Specific Survival and Medication Cost for Patients With Non-Small Cell Lung CancerJuanyi Tan, Szu-Chun Yang, Michaela A Dinan, et al.
JAMA Oncology|July 17, 2015
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009Michaela A Dinan, Xiaojuan Mi, Shelby D Reed, et al.
Journal of Geriatric Oncology|September 11, 2020
Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012Michaela A Dinan, Mihaela V Georgieva, Yanhong Li, et al.
JAMA Internal Medicine|February 17, 2015
Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misusePaolo Goffredo, Samantha M Thomas, Michaela A Dinan, et al.
Journal of Oncology Practice|October 16, 2019
Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian CancerHaley A Moss, Laura J Havrilesky, Frances F Wang, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Trauma and Acute Care Surgery|July 25, 2014
An acute care surgery fellowship benefits a general surgical residencyKelly A Dinan, James W Davis, Mary M Wolfe, et al.
BMC Bioinformatics|February 27, 2010
SplicerAV: a tool for mining microarray expression data for changes in RNA processingTimothy J Robinson, Michaela A Dinan, Mark Dewhirst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid CancerTimothy J Robinson, Samantha Thomas, Michaela A Dinan, et al.
Endocrine|December 29, 2015
Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancerEwa Ruel, Samantha Thomas, Michaela A Dinan, et al.
Journal of General Internal Medicine|August 22, 2006
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosureKevin P Weinfurt, Joëlle Y Friedman, Jennifer S Allsbrook, et al.
JAMA Network Open|June 10, 2025
Biomarker-Specific Survival and Medication Cost for Patients With Non-Small Cell Lung CancerJuanyi Tan, Szu-Chun Yang, Michaela A Dinan, et al.
JAMA Oncology|July 17, 2015
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009Michaela A Dinan, Xiaojuan Mi, Shelby D Reed, et al.
Journal of Geriatric Oncology|September 11, 2020
Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012Michaela A Dinan, Mihaela V Georgieva, Yanhong Li, et al.
JAMA Internal Medicine|February 17, 2015
Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misusePaolo Goffredo, Samantha M Thomas, Michaela A Dinan, et al.
Journal of Oncology Practice|October 16, 2019
Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian CancerHaley A Moss, Laura J Havrilesky, Frances F Wang, et al.
Pageof 12